Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZOETIS INC.

(ZTS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Zoetis : Top Company for Executive Women

11/18/2021 | 11:53am EST

This week, Zoetis earned a top 10 spot on Seramount's 2021 "Top 75 Companies for Executive Women" list. Formerly known as the National Association of Female Executives (NAFE) award, this list celebrates companies that champion women's advancement, with a focus on succession planning, profit-and-loss roles, gender pay parity, support programs and work-life balance programs.

"We are honored to once again be recognized by Seramount for our focus on developing and advancing women," said Evelyn Ortiz, Chief Talent, Diversity, Equity and Inclusion Officer. "We strive to create a diverse and inclusive environment where colleagues are recognized and rewarded for their achievements - and supported as they pursue their unique career goals and aspirations."

The top 10 companies are as follows (in alphabetical order): Bon Secours Mercy Health System; Colgate-Palmolive Company; FleishmanHillard; Johnson & Johnson; L'Oréal USA; Marriott International, Inc.; Nationwide; State Farm; Unilever; and Zoetis Inc.

To view Seramount's full list of Top Companies for Executive Women, click here.

Disclaimer

Zoetis Inc. published this content on 18 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 November 2021 16:52:08 UTC.


ę Publicnow 2021
All news about ZOETIS INC.
01/13Zoetis Announces FDA Approval of Solensia™ (frunevetmab injection) to Control Ost..
BU
01/13Zoetis Inc. Announces FDA Approval of Solensia™ (frunevetmab injection) to Control..
CI
01/13Zoetis Gets FDA Nod for Solensia to Control Pain in Cats with Osteoarthritis
MT
01/13Solensia Announces U.S. Food and Drug Administration Approves Novel Treatment to Contro..
CI
01/12ZOETIS : 2022 J.P. Morgan Healthcare Conference
PU
01/06Zoetis Announces Expanded Commitments to Protect the Planet
BU
01/05ZOETIS : Announces FDA Approval of Simparica Trio« (sarolaner, moxidectin, and pyrantel ch..
PU
2021Zoetis to Participate in the 40th Annual J.P. Morgan Healthcare Conference
BU
2021Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2021 Financi..
BU
2021Citigroup Adjusts Price Target on Zoetis to $232 From $184, Maintains Neutral Rating
MT
More news
Analyst Recommendations on ZOETIS INC.
More recommendations
Financials (USD)
Sales 2021 7 748 M - -
Net income 2021 2 020 M - -
Net Debt 2021 3 092 M - -
P/E ratio 2021 47,2x
Yield 2021 0,49%
Capitalization 94 900 M 94 900 M -
EV / Sales 2021 12,6x
EV / Sales 2022 11,5x
Nbr of Employees 11 300
Free-Float 94,1%
Chart ZOETIS INC.
Duration : Period :
Zoetis Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZOETIS INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 16
Last Close Price 200,58 $
Average target price 245,00 $
Spread / Average Target 22,1%
EPS Revisions
Managers and Directors
Kristin C. Peck Chief Executive Officer & Director
Wetteny Joseph CFO, EVP & Head-Business Development
Michael B. McCallister Non-Executive Chairman
Wafaa Mamilli Chief Information & Digital Officer
Robert J. Polzer Executive VP, President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
ZOETIS INC.-17.81%94 900
ELANCO ANIMAL HEALTH INCORPORATED-7.01%12 485
DECHRA PHARMACEUTICALS PLC-22.52%6 094
VIRBAC-7.66%3 756
JINYU BIO-TECHNOLOGY CO., LTD.-6.36%2 699
WUHAN KEQIAN BIOLOGY CO.,LTD2.54%2 069